Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/2018

01-12-2018 | Editorial

Dietary regulation of metastasis

Author: Jonathan P. Sleeman

Published in: Clinical & Experimental Metastasis | Issue 8/2018

Login to get access

Abstract

The impact of diet and associated lifestyle choices on the risk of developing cancer is well established. However, whether these parameters also affect cancer recurrence and survival is less well investigated. Virtually nothing is known about the impact of diet on the development of metastases. It is therefore significant that a study in this issue of Clinical and experimental metastasis reports that breast cancer-bearing mice fed on a diet rich in long-chain omega-3 fatty acids had a lower incidence of metastasis than control mice, which was associated with modified infiltration of immune cells into the tumors. These findings should form the basis of further pre-clinical evaluation with a view to clinical application.
Literature
1.
go back to reference Mayne ST, Playdon MC, Rock CL (2016) Diet, nutrition, and cancer: past, present and future. Nat Rev Clin Oncol 13:504–515CrossRef Mayne ST, Playdon MC, Rock CL (2016) Diet, nutrition, and cancer: past, present and future. Nat Rev Clin Oncol 13:504–515CrossRef
2.
go back to reference Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, de Braud F (2018) Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol/Hematol 123:57–73CrossRef Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, de Braud F (2018) Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol/Hematol 123:57–73CrossRef
3.
go back to reference Thiele W, Rothley M, Teller N, Jung N, Bulat B, Plaumann D, Vanderheiden S, Schmaus A, Cremers N, Goppert B, Dimmler A, Eschbach V, Quagliata L, Thaler S, Marko D, Brase S, Sleeman JP (2013) Delphinidin is a novel inhibitor of lymphangiogenesis, but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats. Carcinogenesis 34:2804–2813CrossRef Thiele W, Rothley M, Teller N, Jung N, Bulat B, Plaumann D, Vanderheiden S, Schmaus A, Cremers N, Goppert B, Dimmler A, Eschbach V, Quagliata L, Thaler S, Marko D, Brase S, Sleeman JP (2013) Delphinidin is a novel inhibitor of lymphangiogenesis, but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats. Carcinogenesis 34:2804–2813CrossRef
5.
go back to reference Zhang Y, Zhuang P, He W, Chen JN, Wang WQ, Freedman ND, Abnet CC, Wang JB, Jiao JJ (2018) Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421309 individuals. J Intern Med 284:399–417CrossRef Zhang Y, Zhuang P, He W, Chen JN, Wang WQ, Freedman ND, Abnet CC, Wang JB, Jiao JJ (2018) Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421309 individuals. J Intern Med 284:399–417CrossRef
6.
go back to reference Daenen LG, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JM, van Tinteren H, Ishihara K, Huitema AD, Verhoeven-Duif NM, Voest EE (2015) Increased plasma levels of chemoresistance-inducing fatty acid 16:4(n-3) after consumption of fish and fish oil. JAMA Oncol 1:350–358CrossRef Daenen LG, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JM, van Tinteren H, Ishihara K, Huitema AD, Verhoeven-Duif NM, Voest EE (2015) Increased plasma levels of chemoresistance-inducing fatty acid 16:4(n-3) after consumption of fish and fish oil. JAMA Oncol 1:350–358CrossRef
Metadata
Title
Dietary regulation of metastasis
Author
Jonathan P. Sleeman
Publication date
01-12-2018
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 8/2018
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-018-9948-0

Other articles of this Issue 8/2018

Clinical & Experimental Metastasis 8/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine